Absorptive capacity and openness of small biopharmaceutical firms – a European Union–United States comparison
Article first published online: 14 JUL 2013
© 2013 The Author. R&D Management © 2013 John Wiley & Sons Ltd and RADMA
Volume 43, Issue 4, pages 333–351, September 2013
How to Cite
Xia, T. (2013), Absorptive capacity and openness of small biopharmaceutical firms – a European Union–United States comparison. R&D Management, 43: 333–351. doi: 10.1111/radm.12017
- Issue published online: 13 AUG 2013
- Article first published online: 14 JUL 2013
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!